Certest and TÜV Rheinland, a story of success
España | 23 January, 2025
Certest and TÜV Rheinland, a story of success

Certest Biotec has obtained the CE IVDR certificate for a total of 46 of its products, corresponding to more than 575 references in its catalogue, thanks to its collaboration with the notified body TÜV Rheinland.
A major achievement that reinforces its commitment to quality, safety and compliance that would not have been possible to achieve without the support of TÜV Rheinland.
This milestone reinforces Certest's commitment to its customers, distributors, end users and patients, to provide them with products of the highest quality, efficacy and safety, while, in the words of its CEO Nelson Fernandes: It allows us to significantly improve our processes and enables to continue working day by day to be the biotechnological reference that we have become over these more than 20 years of effort and work.
About Certest
Certest Biotec is a biotechnology company founded in 2002 in Zaragoza (Spain), focused on the development, manufacturing, and commercialization of IVD and biotech products, as well as on the diagnosis of infectious diseases.
Certest Biotec consists of four divisions, including Raw Materials, Immunodiagnostics (Rapid Tests, Turbidimetry, and CLIA), Molecular Biology under the VIASURE brand, and Pharma.
With an annual turnover of more than 38 million euros in 2024, it has more than 25,000 square meters of facilities and more than 300 employees, enabling it to be present in more than 130 countries through its network of distributors.
Certest Biotec stands out in its sector for its strong commitment to R&D, reinvesting almost 15% of its annual profits to improve the efficiency of its production processes and adapt to the constant changes in the market.
Website: www.certest.es